http://www.pharmachemm.com
Home > Products > Anticancer/Antitumor/Antineoplastic > Apixaban Intermediate CAS 503615-03-0 Intermediate 3

Apixaban Intermediate CAS 503615-03-0 Intermediate 3

    Unit Price: USD 2.5 - 250 / Gram
    Payment Type: L/C,D/P,Paypal,Money Gram,Western Union
    Incoterm: FOB,CFR,CIF,FCA,CPT,CIP
    Min. Order: 1 Gram
    Delivery Time: 1 Days
Basic Info

Model No.: JF01-28

Function: Urinary System Agents, Central Nervous System Agents, Enzymes and Other Biochemical, Nervous System Drugs, Drug Detoxification, Regulating Water and Salt, Electrolyte and Acid-Base Balance of Medicine, Specialist Drugs, Original Drug Resistant Microbes, Antineoplastic

Certification: FDA, GMP, GMP

Grade Standard: Medicine Grade, Medicine Grade

Type: Analysis reagent, Medicinal Chemical

State: Solid

Volatile: Not Volatile

Purity: 99%

Description: WHITE

Storage: Cool

Flash Point: 105℃

Valid Date: 2 Years

Brand Name: Jianfeng

CAS No: 503615-03-0

Additional Info

Packaging: High Purity 503612-47-3 CAS NO Apixaban Drum, bag

Productivity: 2000kg per month

Brand: Jianfeng

Transportation: Ocean,Land

Place of Origin: China

Supply Ability: 2000kg

Certificate: ISO90011

HS Code: 29349990.00

Port: Qingdao,Shanghai,Tianjin

Product Description

Apixaban is the third new oral anticoagulant to go on sale, following dabigatran and rivaroxaban, and it has already been approved in Europe for preventing venous thromboembolism in patients undergoing elective hip or knee replacement surgery. Out of these three oral anticoagulants approved in Europe, compared to the current standard preventative treatment against venous thromboembolism, enoxaparin, rivaroxaban excelled in the record experiment, and apixaban excelled in the advance experiment. Rivaroxaban`s curative effects were slightly superior, but it caused more severe bleeding than apixaban. Researchers attributed these differences to medication time, as rivaroxaban was taken 6-8 hours after surgery in the record experiment, while apixaban was used 18 hours after surgery in the advance experiment. These drugs have better curative effect when used closer to time of surgery, but also have an increased bleeding risk. Clinical research showed that compared to a daily subdermal injection of 40mg enoxaparin, 2 oral 2.5mg dosages of apixaban had better preventative effects against venous thromboembolism following hip or knee replacement surgery and did not increase bleeding risk. in patients following knee and hip replacement surgery.

503615 03 0

Other name of apixaban are Apixaban;Apixaban, BMS 562247-01;1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;BMS 562247-01;1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid aMide;Apixaban, >=99%;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4, 5-dihydropyrazolo[3,4-c]pyridine-3-carboxaMide

Apixaban In Stock No

503615-03-0 High Quality Assurance

Looking for ideal Nilotinib and Its InterMediate 503615-03-0 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Apixaban Rand Name 503615-03-0 are quality guaranteed. We are China Origin Factory of Apixaban 503615-03-0 Dosage. If you have any question, please feel free to contact us.

Product Categories : Anticancer/Antitumor/Antineoplastic

Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Communicate with Supplier?Supplier
Mr. Vid Mr. Mr. Vid
What can I do for you?
Contact Supplier